Stephen King once said, “you can, you should, and if you’re brave enough to start, you will.”
In our quest for enabling groundbreaking and revolutionary technology that can be commercialized to benefit the human civilization and not just a exploratory exercise in biotechnology we incorporated Nanoretina LLC (nano-retina.com). The sole focus of the company is to realize a bionic eye and heal the blind. The technology that was conceived to produce the retinal prosthesis is not just bleeding edge but we believe that when it comes to market, it will be by far the most complex active implant with hundreds of electrodes all residing in the volume of a grain of rice.
We wanted to take this idea further to realize solutions that do not exist today for the human physiology. One of the emerging areas for Bioscience is Targeted Brain Plasticity where we can use a prosthesis to talk to the Peripheral Nervous System (PNS) using a very small prosthesis and cause changes in the brain using targeted therapy. The idea is to use your own body’s natural mechanism of rewiring the brain to help heal ailments.
This is an alternative to the current pharmacology solutions requiring medical drugs. We believe that this new Bioelectronic medicine is a new start, a new solution to the new age of brain disorders. We have partnered with the Texas Biomedical Device Center (TxBDC-www.utd.edu/txbdc/) under the supervision of Dr. Robert Rennaker at University of Dallas (UTD- www.utd.edu) to develop this platform technology. Dr. Rennaker is the Director of TxBDC and also the Department Head of Bioengineering at UTD with more than 20 years of experience in developing neural interface. The team at Zyvex is very pleased with this joint effort that will enable novel targeted plasticity applications for developing new medical devices for neurological injury and repair. Watch this space!